p-Coumaroyl amides have also been evaluated in neurological disorders as inhibitors of enzymes such as acetylcholine esterase, or as agonists/antagonists of synaptic receptors and modulators of neurotransmitter reuptake. This evidence concerns the gene ACHE and nervous system disorder.